Real-time enrollment status for this morning sickness clinical trial
Current Status
Suspended
Checked: April 17, 2026 at 2:25 AM UTC
| NCT Number | NCT05289557 |
| Recruiting Status | Suspended |
| Condition | Morning Sickness |
| Phase | Clinical Trial |
| Target Enrollment | 274 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Duchesnay Inc. |
| Last Updated on CT.gov | April 3, 2026 (2 weeks ago) |
As of April 17, 2026: Clinical trial NCT05289557 is currently suspended participants. This clinical trial study for morning sickness is not currently accepting new participants at 10 locations across the United States. The study is sponsored by Duchesnay Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05289557 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05289557 was last updated 2 weeks ago (April 3, 2026). HelloStudys verifies this status automatically.